ImmunityBio, Inc. Class Action Lawsuit
Company: ImmunityBio, Inc.
Ticker: (NASDAQ) IBRX
Class Action Period: January 19, 2026 - March 24, 2026
See If You Qualify For Monetary Reward
Join the ImmunityBio, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
January 19, 2026 - March 24, 2026
Allegations
The complaint filed against ImmunityBio, Inc. alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (1) defendant Soon-Shion materially overstated Anktiva’s capabilities; and (2) as a result, defendants’ statements about ImmunityBio’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Eligibility
To join the lawsuit, you must have experienced a loss on ImmunityBio, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in ImmunityBio, Inc. during the relevant time frame, you have until May 26, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against ImmunityBio, Inc. (NASDAQ: IBRX)?
Investors who purchased shares of ImmunityBio, Inc. (NASDAQ: IBRX) during the class period (January 19, 2026 - March 24, 2026) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is May 26, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the ImmunityBio, Inc. lawsuit?
Anyone who bought shares of ImmunityBio, Inc. (NASDAQ: IBRX) during January 19, 2026 - March 24, 2026 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the ImmunityBio, Inc. case?
The lead plaintiff deadline for the ImmunityBio, Inc. lawsuit is May 26, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for ImmunityBio, Inc.?
The class period for ImmunityBio, Inc. (NASDAQ: IBRX) is January 19, 2026 - March 24, 2026, during which investors may have been affected by alleged misconduct.
- Can I still join the ImmunityBio, Inc. lawsuit if I sold my shares?
Yes. Investors who purchased ImmunityBio, Inc. shares during January 19, 2026 - March 24, 2026 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the ImmunityBio, Inc. lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the ImmunityBio, Inc. case may receive a portion of the recovery.
- Do I need to pay to participate in the ImmunityBio, Inc. case?
No, most securities fraud cases involving ImmunityBio, Inc. operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the ImmunityBio, Inc. lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the ImmunityBio, Inc. case on behalf of participants.
- What documents are required for the ImmunityBio, Inc. lawsuit?
To participate in the ImmunityBio, Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for ImmunityBio, Inc.?
After submission, your details for the ImmunityBio, Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the ImmunityBio, Inc. lawsuit?
No, this page provides information about the ImmunityBio, Inc. case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the ImmunityBio, Inc. case?
The lead plaintiff deadline for the ImmunityBio, Inc. lawsuit is May 26, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
Kyndryl Holdings, Inc.
KD
Lead Plaintiff Deadline: April 13, 2026
Class Period: August 1, 2024 - February 9, 2026
uniQure N.V.
QURE
Lead Plaintiff Deadline: April 13, 2026
Class Period: September 24, 2025 - October 31, 2025